Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
Jump to:
Preferred Name | Esketamine | |
Synonyms |
|
|
Definitions |
A cyclohexanone derivative and S-enantiomer of racemic ketamine, with analgesic, anesthetic and antidepressant activities. Although the mechanism of action is not fully understood, upon administration, esketamine targets, non-competitively binds to, and blocks N-methyl D-aspartate (NMDA) receptors. This reduces pain perception, induces sedation, and produce dissociative anesthesia. |
|
ID |
http://purl.obolibrary.org/obo/NCIT_C81400 |
|
CAS_Registry |
33643-46-8
|
|
CHEBI_ID |
CHEBI:60799
|
|
Chemical_Formula |
C13H16ClNO
|
|
code |
C81400
|
|
Contributing_Source |
FDA
|
|
definition |
A cyclohexanone derivative and S-enantiomer of racemic ketamine, with analgesic, anesthetic and antidepressant activities. Although the mechanism of action is not fully understood, upon administration, esketamine targets, non-competitively binds to, and blocks N-methyl D-aspartate (NMDA) receptors. This reduces pain perception, induces sedation, and produce dissociative anesthesia.
|
|
FDA_UNII_Code |
50LFG02TXD
|
|
in_subset | ||
label |
Esketamine
|
|
Legacy Concept Name |
Esketamine
|
|
Preferred_Name |
Esketamine
|
|
prefixIRI |
NCIT:C81400
|
|
prefLabel |
Esketamine
|
|
Semantic_Type |
Pharmacologic Substance
|
|
UMLS_CUI |
C2825616
|
|
subClassOf |
Add comment
Delete | Subject | Author | Type | Created |
---|---|---|---|---|
No notes to display |
Create mapping